These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7689459)

  • 21. Selective oral decontamination in cystic fibrosis: an attempt to prevent pseudomonas colonisation.
    Dalzell AM; van Saene HK; Heaf DP
    Acta Univ Carol Med (Praha); 1990; 36(1-4):40-1. PubMed ID: 2130715
    [No Abstract]   [Full Text] [Related]  

  • 22. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
    Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN
    Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofloxacin: comparative data in cystic fibrosis.
    Rubio TT
    Am J Med; 1987 Apr; 82(4A):185-8. PubMed ID: 3555034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature.
    Marchetti F; Giglio L; Candusso M; Faraguna D; Assael BM
    Eur J Clin Pharmacol; 2004 Apr; 60(2):67-74. PubMed ID: 15004732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoroquinolone-resistant Pseudomonas aeruginosa in chronic rhinosinusitis.
    Guss J; Abuzeid WM; Doghramji L; Edelstein PH; Chiu AG
    ORL J Otorhinolaryngol Relat Spec; 2009; 71(5):263-7. PubMed ID: 19797934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis].
    Croize J; Gout JP; Robert J; Le Noc P
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):573-7. PubMed ID: 2508041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus.
    Buchs C; Dalphin ML; Sanchez S; Perceval M; Coutier L; Mainguy C; Kassaï-Koupaï B; Reix P
    Eur J Pediatr; 2017 Jul; 176(7):891-897. PubMed ID: 28508992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa.
    Kaye KS; Kanafani ZA; Dodds AE; Engemann JJ; Weber SG; Carmeli Y
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2192-6. PubMed ID: 16723582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of quinolones in the treatment of Pseudomonas aeruginosa infections in children with cystic fibrosis].
    Milio MC; Campana S
    Pediatr Med Chir; 1995; 17(1):53-5. PubMed ID: 7739928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradication of early Pseudomonas aeruginosa infection.
    Høiby N; Frederiksen B; Pressler T
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():49-54. PubMed ID: 16023416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients.
    Marchetti F; Candusso M; Faraguna D; Assael BM
    Lancet; 2002 Feb; 359(9306):626-7. PubMed ID: 11867141
    [No Abstract]   [Full Text] [Related]  

  • 33. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
    Dajcs JJ; Thibodeaux BA; Marquart ME; Girgis DO; Traidej M; O'Callaghan RJ
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients.
    Cantón R; Máiz L; Escribano A; Olveira C; Oliver A; Asensio O; Gartner S; Roma E; Quintana-Gallego E; Salcedo A; Girón R; Barrio MI; Pastor MD; Prados C; Martínez-Martínez MT; Barberán J; Castón JJ; Martínez-Martínez L; Poveda JL; Vázquez C; de Gracia J; Solé A;
    Arch Bronconeumol; 2015 Mar; 51(3):140-50. PubMed ID: 25614377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.
    Scully BE; Jules K; Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):336-8. PubMed ID: 3578324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and future of the aerosoltherapy in the treatment of cystic fibrosis patients infected by Pseudomonas aeruginosa].
    Rognon A; Curti C; Montana M; Terme T; Rathelot P; Vanelle P
    Therapie; 2011; 66(6):481-91. PubMed ID: 22186073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
    Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
    Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
    Cheer SM; Waugh J; Noble S
    Drugs; 2003; 63(22):2501-20. PubMed ID: 14609360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and pharmacokinetics of ciprofloxacin dry powder for inhalation in cystic fibrosis: a phase I, randomized, single-dose, dose-escalation study.
    Stass H; Delesen H; Nagelschmitz J; Staab D
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):106-15. PubMed ID: 25050456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.